Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

5 Revenue-Growing Biotechs With Attractive Fundamentals
Seeking Alpha
Thursday, November 7, 2013 - 9:49am
tags:
Jazz Pharmaceuticals, Alexion, Questcor, Celgene, Regeneron
Omeros' OMS721 shows positive Phase 1 clinical trial results
Yahoo/Fly on the Wall
Thursday, November 7, 2013 - 9:48am
tags:
Omeros, OMS721
New Roche leukemia drug shows clear advantage over Rituxan-study
Yahoo/Reuters
Thursday, November 7, 2013 - 9:46am
tags:
Roche, Rituxan, GA101, Gazyva
Geron soars after myelofibrosis drug shows 44% response rate
The Fly on the Wall
Thursday, November 7, 2013 - 9:45am
tags:
myelofibrosis, Geron, imetelstat
Pozen Inc: Huge Special Dividend And PDUFA On The Horizon Equal Big Gains
Seeking Alpha
Thursday, November 7, 2013 - 8:18am
tags:
Pozen, Omeprazole, Sanofi, PA8140
Glaxo Sells Bad With Good in Safety Push Amid China Woes
Bloomberg
Thursday, November 7, 2013 - 8:16am
tags:
GSK, China
Novartis to add 175 jobs in Cambridge, cut elsewhere
Boston Globe, MA
Thursday, November 7, 2013 - 8:15am
tags:
Novartis, Boston, restructuring
Alnylam 4Q loss widens on fewer drug partnerships
Yahoo/AP
Thursday, November 7, 2013 - 8:13am
tags:
Alnylam, earnings
The Good, Bad, and Ugly of VIVUS' Earnings
Motley Fool
Thursday, November 7, 2013 - 8:11am
tags:
Vivus, earnings
Questcor: Continued Strong Earnings Will Drive It Over $90
Seeking Alpha
Thursday, November 7, 2013 - 8:10am
tags:
Questcor, earnings
Troubled Merck Puts Hopes in New HPV Vaccine
Motley Fool
Wednesday, November 6, 2013 - 5:13pm
tags:
HPV, vaccines, Merck, V503
With Qsymia still flailing, Vivus to cut 20 jobs, replace CFO
Fierce Pharma
Wednesday, November 6, 2013 - 3:37pm
tags:
Vivus, layoffs, Qsymia
AstraZeneca Asks Court Not to Revive Whistleblower Suit
Bloomberg
Wednesday, November 6, 2013 - 3:33pm
tags:
AstraZeneca, Medco, whistleblower lawsuits, kickbacks
What's Next for This Biotech?
Motley Fool
Wednesday, November 6, 2013 - 3:32pm
tags:
Exelixis
Rockwell Medical: Significant Growth Potential With New State-Of-The-Art Dialysis Drug
Seeking Alpha
Wednesday, November 6, 2013 - 11:23am
tags:
Rockwell Medical, dialysis, Soluble Ferric Pyrophosphate
Jazz Pharma Q3 Solid, But Competitive Worries Loom
Investors.com
Wednesday, November 6, 2013 - 11:21am
tags:
earnings, Jazz Pharmaceuticals
InterMune says it is selling 6.5M shares to fund marketing and studies of lung disease drug
Yahoo/AP
Wednesday, November 6, 2013 - 11:21am
tags:
InterMune, stock offering, Esbriet
Isis Pharma Posts Lower Q3 Loss
Yahoo/Zacks
Wednesday, November 6, 2013 - 11:20am
tags:
earnings, Isis Pharmaceuticals
Analyst ranks the top 11 pharma giants' prospects, putting GSK on top
Fierce Biotech
Wednesday, November 6, 2013 - 10:39am
tags:
GSK, Bayer, Sanofi, Novartis, JNJ, Bristol-Myers Squibb, Merck, AbbVie, Eli Lilly, Pfizer, AstraZeneca
FDA puts a clamp on Curis cancer drug program after patient dies of liver failure
Fierce Biotech
Wednesday, November 6, 2013 - 10:37am
tags:
liver failure, Genentech, FDA, Curis, CUDC-427, breast cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.